ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Navigating treatment decisions in NSCLC"
Episode Synopsis
Listen to a medical oncologist, a pathologist and an oncology nurse practitioner discuss the evolving treatment landscape and how treatment decisions need to take into account potential side effects.
The multidisciplinary team
Medical oncologist: Dr Alexander Drilon, USA
Pathologist: Prof. Keith Kerr, UK
Oncology nurse practitioner: Dr Marianne Davies, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-navigating-diagnosis-and-treatment-nsclc/
The multidisciplinary team
Medical oncologist: Dr Alexander Drilon, USA
Pathologist: Prof. Keith Kerr, UK
Oncology nurse practitioner: Dr Marianne Davies, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-navigating-diagnosis-and-treatment-nsclc/
In God we trust